🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Beyonce's Peloton Deal Not Enough to Counter Vaccine News

Published 2020-11-10, 11:09 a/m
© Reuters
PFE
-
PTON
-

By Christiana Sciaudone

Investing.com --  If even having Beyonce on your side isn't enough to pull out a win, it's looking pretty bad for the rest of humanity. 

Peloton (NASDAQ:PTON) sank 6% even after announcing a long-term deal with the songstress. Shares did recover some and are trading little changed. 

The exercise bike maker fell some 20% on Monday after Pfizer (NYSE:PFE)'s announced that its Covid-19 vaccine candidate is 90% effective, and markets celebrated the real possibility that we will finally be unleashed from lockdown.

Peloton reported strong results last week, but is facing challenges in keeping up with demand.

Beyonce and Peloton have created a series of themed workout experiences to help extend Homecoming season at Historically Black Colleges and Universities. Peloton members, of which there are more than 3.6 million, will have access to classes across multiple categories, including indoor cycling, running, strength, bootcamp, yoga and meditation.

As part of the partnership, Beyonce and Peloton will gift two-year Peloton Digital memberships to students at 10 of the schools. The classes will be available for use with or without a Peloton bike. Peloton will also pursue long-term recruiting partnerships at both the internship and undergraduate levels at the schools. 

In the coming months, Beyonce will continue to work closely with Peloton on class curation across all workout disciplines.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.